EGFR and lung adenocarcinoma: Although the co-occurrence of EGFR mutations and amplifications has been observed before, it is typically much less pronounced than was observed in our study (e.g., the recent whole-genome analysis of 183 lung adenocarcinomas with the use of massively parallel sequencing [33]).